Balziva
Product Images NDC 53002-1725

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Balziva (NDC 53002-1725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

00555903458part1of2

00555903458part1of2
FDA Label Image

00555903458part2of2

00555903458part2of2
FDA Label Image

Structural Formulas (Image 1)

Structural Formulas (Image 1)
FDA Label Image

Figure 1: Circulatory Disease Mortality Rates Per 100,000 Women-years By Age, Smoking Status And Oral Contraceptive Use (Image 2)

Figure 1: Circulatory Disease Mortality Rates Per 100,000 Women-years By Age, Smoking Status And Oral Contraceptive Use (Image 2)
This appears to be a table with mortality rates expressed as the number of deaths per 100,000 adult women users, broken down by age ranges and smoking status. The data seems to show different mortality rates for ever-users who are smokers compared to ever-users who are nonsmokers. However, without further information it is difficult to provide more context or insights.*
FDA Label Image

Blister Image (Image 3)

Blister Image (Image 3)
Tronly Store at 20-25°C (68-77°F) [See USP Controlled Room Temperature]. This text appears to be instructions for storage of something, possibly medication, but it is not clear what the item being stored is.*
FDA Label Image

Label Image (Lbl530021725)

Label Image (Lbl530021725)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.